Development of a multi-mimotope peptide as a vaccine immunogen for infectious bursal disease virus

Vaccine

Volumn 25, Issue 22, 2007, Pages 4447-4455

  Wang, Yong shan ^a,b,c   Fan, Hong jie ^b   Li, Yin ^c   Shi, Zheng liang ^a   Pan, Ying ^a   Lu, Cheng ping ^b  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b NANJING AGRICULTURAL UNIVERSITY   (China)

^c INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

Infectious bursal disease virus (IBDV); Multi mimotope peptide; Subunit vaccine

Indexed keywords

EPITOPE; FREUND ADJUVANT; INFECTIOUS BURSAL DISEASE VACCINE; MONOCLONAL ANTIBODY; NEUTRALIZING ANTIBODY; POLYCLONAL ANTIBODY; RECOMBINANT VACCINE; UNCLASSIFIED DRUG; VIRUS ANTIGEN; VIRUS PROTEIN; VIRUS VACCINE;

AMINO ACID SEQUENCE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ANTIGEN BINDING; ARTICLE; CHICKEN; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; ESCHERICHIA COLI; GENE EXPRESSION SYSTEM; IMMUNIZATION; INFECTIOUS BURSAL DISEASE VIRUS; MOLECULAR CLONING; MOLECULAR WEIGHT; NONHUMAN; NUCLEOTIDE SEQUENCE; PEPTIDE SYNTHESIS; PHAGE DISPLAY; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROKARYOTE; PROTECTION; RECOMBINANT DNA TECHNOLOGY; SURVIVAL RATE; VIRUS INFECTION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANIMALS; ANTIBODIES, MONOCLONAL; ANTIBODIES, VIRAL; BIRNAVIRIDAE INFECTIONS; CHICKENS; EPITOPES, T-LYMPHOCYTE; INFECTIOUS BURSAL DISEASE VIRUS; MICE; MICE, INBRED BALB C; MOLECULAR MIMICRY; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; POULTRY DISEASES; RABBITS; VIRAL PROTEINS; VIRAL VACCINES;

EID: 34247569923     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.03.018     Document Type: Article

References (59)

1. Lukert P.D., and Saif Y.M. Infectious bursal disease. In: Calnek B.W. (Ed). Diseases of poultry. 10th ed. (1997), Iowa State University Press, Ames 721-738
2. Muller H., Islam M.R., and Raue R. Research on infectious bursal disease-the past, the present and the future. Vet Microbiol 97 (2003) 153-165
3. Brown F. The classification and nomenclature of viruses: summary of results of meetings of the international committee on taxonomy of viruses in Sendai, September 1984. Intervirology 25 (1986) 141-143
4. Dobos P., Hill B.J., Hallett R., Kells D.T.C., Becht H., and Teninges D.T. Biophysical and biochemical characterization of five animal viruses with bisegmented double-stranded RNA genomes. J Virol 32 (1979) 593-605
5. Mundt E., Beyer J., and Muller H. Identification of a novel viral protein in infectious bursal disease virus-infected cells. J Gen Virol 76 (1995) 437-443
6. Mundt E., Kollner B., and kretzschmar D. VP5 of infectious bursal disease virus is not essential for virus replication in cell culture. J Virol 71 (1997) 5647-5651
7. Hudson P.J., Mckern N.M., Power B.E., and Azad A.A. Genomic structure of the large RNA segment of infectious bursal disease virus. Nucleic Acids Res 14 (1986) 5001-5012
8. Muller H., and Nitschke R. The two segments of the infectious bursal disease virus genome are circularized by a 90000-Da protein. Virology 159 (1987) 174-177
9. Azad A.A., Jagadish M.N., Brown M.N., and Hudson P.J. Deletion mapping and expression in Escherichia coli of the large genomic segment of a birnavirus. Virology 161 (1987) 145-152
10. Becht H., Muller H., and Muller H.K. Comparative studies on structural and antigenic properties of two serotypes of infectious bursal disease virus. J Gen Virol 69 (1988) 631-640
11. Fahey K.J., Erny K., and Crooks J. A conformational immunogen on VP2 of infectious bursal disease virus that induces virus-neutralizing antibodies that passively protect chickens. J Gen Virol 70 (1989) 1473-1481
12. Huang Z., Elankumaran S., Yunus A.S., and Samal S.K. A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J Virol 78 (2004) 10054-10063
13. Bayliss C.D., Spies U., Shaw K., Peters R.W., Pagageorgiou A., Müller H., et al. A comparison of the sequences of segment A of four infectious bursal disease virus strains and identification of a variable region of VP2. J Gen Virol 71 (1990) 1303-1312
14. Heine H.G., Haritou M., Failla P., Fahey K., and Azad A. Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type 1 strains. J Gen Virol 72 (1991) 1835-1843
15. Schnitzler D., Bernstein F., Muller H., and Becht H. The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus. J Gen Virol 74 (1993) 1563-1571
16. Cui X., Nagesha H.S., and Holmes I.H. Mapping of conformational epitopes on capsid protein VP2 of infectious bursal disease virus by fd-tet phage display. J Virol Methods 114 (2003) 109-112
17. Cui X., Nagesha H.S., and Holmes I.H. Identification of crucial residues of conformational epitopes on VP2 protein of infectious bursal disease virus by phage display. J Virol Methods 109 (2003) 75-83
18. Oppling V., Muller H., and Becht H. Heterogeneity of the antigenic site responsible for the induction of neutralizing antibodies in infectious bursal disease virus. Arch Virol 119 (1991) 211-223
19. Wang X.N., Zhang G.P., Zhou J.Y., Feng C.H., Yang Y.Y., Li Q.M., et al. Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping. Viral Immunol 18 (2005) 549-557
20. Nagarajan M.M., and Kibenge F.S.B. Infectious bursal disease virus: a review of molecular basis for variations in antigenicity and virulence. Can J Vet Res 61 (1997) 81-88
21. Cui Z.Z., Sun S.H., Shan Z.F., Jiang Y.W., and Jin W.J. Pathogenicity of a very virulent strain GX8/99 of infectious bursal disease virus. Chin J Virol 18 (2002) 162-166
22. Snyder D.B., Lana D.P., Savage P.K., Yancey F.S., Mengel S.A., and Marquardt W.W. Differentiation of infectious bursal disease viruses directly from infected tissues with neutralizing monoclonal antibodies: evidence of a major antigenic shift in recent field isolates. Avian Dis 32 (1988) 535-539
23. Cao Y.C., Bi Y.Z., Leung F.C., and Lim B.L. Molecular signature of host-protective antigen of highly virulent strains of infectious bursal disease virus. Chin J Vet Sci 18 (1998) 521-526
24. Azad A.A., Fahey K.J., Barrett S.A., Emy K.M., and Hudaon P.J. Expression in Escherichia coli of cDNA fragments encoding the gene for the host-protective antigen of infectious bursal disease virus. Virology 149 (1986) 190-198
25. Jagadish M.N., Vaugham P.R., Irving R.A., Azad A.A., and Macreadie I.G. Expression and characterization of infectious bursal disease virus polyprotein in yeast. Gene 95 (1990) 179-186
26. Macreadie I.G., Vaughan P.R., Chapman A.J., Mckern N.M., Jaqadish M.N., Heine H.G., et al. Passive protection against infectious bursal disease virus by viral VP2 expressed in yeast. Vaccine 8 (1990) 549-552
27. Wang X.M., Wang M.P., Gao H.L., Fu Z.Y., Zeng X.W., and Zhang S.F. High-efficiency expression of the major antigen gene VP2 of infectious bursal disease virus in yeast and rudimentary immunization test. Sci Agric Sinica 36 (2003) 443-447
28. Ward G.A., Stover C.K., Moss B., and Fuerst T.R. Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells. Proc Natl Acad Sci USA 92 (1995) 6773-6777
29. Fernandez-Arias A., Risco C., Martinez S., Albar J.P., and Rodriguez J.F. Expression of ORF A1 of infectious bursal disease virus results in the formation of virus-like particles. J Gen Virol 79 (1998) 1047-1054
30. Shaw I., and Davison T.F. Protection from IBDV-induced bursal damage by a recombinant fowlpox vaccine, fpIBD1, is dependent on the titre of challenge virus and chicken genotype. Vaccine 18 (2000) 3230-3241
31. Vakharia V.N., Snyder D.V., He J., Edwards G.H., Savage P.K., and Mengel-Whereat S.A. Infectious bursal disease virus structural proteins expressed in a baculovirus recombinant confer protection in chickens. J Gen Virol 74 (1993) 1202-1206
32. Snyder D.B., Vakharia V.N., Mengel-Whereat S.A., Edwards G.H., Savage P.K., Lutticken D., et al. Active cross-protection induced by a recombinant baculovirus expressing chimeric infectious bursal disease virus structural proteins. Avian Dis 38 (1994) 701-707
33. Lu M.J., Li J.R., Wang Y.F., Jin Y.F., and Yu L. Expression of polyprotein of infectious bursal disease virus in Bombyx mori. Chin J Biotechnol 18 (2002) 472-476
34. Fodor I., Horvath E., Fodor N., Nagy E., Rencendorsh A., Vakharia V.N., et al. Induction of protective immunity in chickens immunized with plasmid DNA encoding infectious bursal disease virus antigens. Acta Vet Hung 47 (1999) 481-492
35. Li L., Fang W.H., Fan Y.J., Xu J., Fang L., Li J.R., et al. Expression of the infectious bursal disease virus polyprotein in vero cells using attenuate Salmonella typhimurium as transgenic carrier. Chin J Biotechnol 20 (2004) 437-440
36. Wang Y.S., Zhou Z.A., Liu Y., Li Y., Luo H.L., Deng X.Z., et al. Serological analysis and immunologic test of infectious bursal disease viruses highly expressing VP2. Chin J Vet Sci 22 (2002) 114-115
37. Thompson J.D., Higgins D.G., and Gibson T.J. CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res 22 (1994) 4673-4680. http://www.ebi.ac.uk/clustalw/index.html
38. Sambrook J., Fritsch E.F., and Maniatis T. Molecular cloning: a laboratory manual. 2nd ed. (1989), Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
39. Dodds W.J. More bumps on the vaccine road. Adv Vet Med 41 (1999) 715-732
40. Jackwood M.W. Current and future recombinant viral vaccines for poultry. Adv Vet Med 41 (1999) 517-522
41. Studier F.W. Use of bacteriophage T7 lysozyme to improve an inducible T7 expression system. J Mol Biol 219 (1991) 37-44
42. Studier F.W., Rosenberg A.H., Dunn J.J., and Dubendorff J.W. Use of T7 RNA polymerase to direct expression of cloned genes. Methods Enzymol 185 (1990) 60-89
43. Yamaguchi T., Iwata K., Kobayashi M., Ogawa M., Fukushi H., and Hirai K. Epitope mapping of capsid proteins VP2 and VP3 of infectious bursal disease virus. Arch Virol 141 (1996) 1493-1507
44. Rabinovich N.R., Mclnnes P., Klein D.L., and Hall B.F. Vaccine technologies: view to the future. Science 265 (1994) 1401-1404
45. Charalambous B.M., and Feavers I.M. Mimotope vaccines. J Med Microbiol 50 (2001) 937-939
46. Pashov A.D., Plaxco J., Kaveri S.V., Monzavi-Karbassi B., Harn D., and Kieber-Emmons T. Multiple antigenic mimotopes of HIV carbohydrate antigens: relating structure and antigenicity. J Biol Chem 281 (2006) 29675-29683
47. Steward M.W. The development of a mimotope-based synthetic peptide vaccine against respiratory syncytial virus. Biologicals 29 (2001) 215-219
48. Roccasecca R., Folgori A., Ercole B.B., Puntoriero G., Lahm A., Zucchelli S., et al. Mimotopes of the hyper variable region 1 of the hepatitis C virus induce cross-reactive antibodies directed against discontinuous epitopes. Mol Immunol 38 (2001) 485-492
49. Enshell-Seijffers D., Denisov D., Groisman B., Smelyanski L., Meyuhas R., Gross G., et al. The mapping and reconstitution of a conformational discontinuous B-cell epitope of HIV-1. J Mol Biol 334 (2003) 87-101
50. Bittle J.L., Houghten R.A., Alexander H., Shinnick T.M., Sutcliffe J.G., Lerner R.A., et al. Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298 (1982) 30-33
51. Broekhuijsen M.P., Blom T., van Rijn J., Pouwels P.H., Klasen E.A., Fasbender M.J., et al. Synthesis of fusion proteins with multiple copies of an antigenic determinant of foot-and-mouth disease virus. Gene 49 (1986) 189-197
52. Villen J., Rodriguez-Mias R.A., Nunez J.I., Giralt E., Sobrino F., and Andreu D. Rational dissection of binding surfaces for mimicking of discontinuous antigenic sites. Chem Biol 13 (2006) 815-823
53. Luzzago A., Felici F., Tramontano A., Pessi A., and Cortese R. Mimicking of discontinuous epitopes by phage-displayed peptides. I. Epitope mapping of human H ferritin using a phage library of constrained peptides. Gene 128 (1993) 51-57
54. Moe G.R., Tan S., and Granoff D.M. Molecular mimetics of polysaccharide epitopes as vaccine candidates for prevention of Neisseria meningitidis serogroup B disease. FEMS Immunol Med Microbiol 26 (1999) 209-226
55. Lesinski G.B., Smithson S.L., Srivastava N., Chen D., Widera G., and Westerink M.A. A DNA vaccine encoding a peptide mimic of Streptococcus pneumoniae serotype 4 capsular polysaccharide induces specific anti-carbohydrate antibodies in BALB/c mice. Vaccine 19 (2001) 1717-1726
56. Livengston B.D., Newnan M., Crimi C., McKinney D., Chesnut R., and Sette A. Optimization of epitope processing enhances immunogenicity of multiepitope DNA vaccines. Vaccine 19 (2001) 4652-4660
57. Velders M.P., Weijzen S., Eiben G.L., Elmishad A.G., Kloetzel P.M., Higgins T., et al. Dedined flanking spacers and enhanced proteolysis is essential for eradication of established tumors by an epitope string DNA vaccine. J Immunol 166 (2001) 5366-5373
58. Jackwood D.H., Saif Y.M., and Hughes J.H. Replication of infectious busal disease virus in continuous cell lines. Avian Dis 31 (1987) 370-375
59. Jackwood D.J., Saif Y.M., and Hughes J.H. Characteristics and serologic studies of two serotypes of infectious bursal disease virus in turkeys. Avian Dis 26 (1982) 871-882